David Altarac Entasis Therapeutics Holdings Inc. (ETTX) insider trading activity

David Altarac is Chief Medical Officer of Entasis Therapeutics Holdings Inc.. Currently has a direct ownership of 0 shares of ETTX, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2022, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

David Altarac Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2022	SELL Sale (or disposition) back to the issuer	-	150,000 Reduced 100.0%	0 Common Stock
Jul 07 2022	SELL Disposition due to a tender of shares in a change of control transaction	$38,658 $2.2 p/Share	17,572 Reduced 100.0%	0 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	125,000 Added 42.72%	167,572 Common Stock
Nov 02 2021	SELL Payment of exercise price or tax liability	$10,787 $2.94 p/Share	3,669 Reduced 7.93%	42,572 Common Stock
Oct 19 2021	SELL Open market or private sale	$11,991 $3.19 p/Share	3,759 Reduced 7.52%	46,241 Common Stock
Oct 19 2021	BUY Grant, award, or other acquisition	-	25,000 Added 33.33%	50,000 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

David Altarac

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETTX shares.

Notify only if

Value

Insider Trading

Get notified when an Entasis Therapeutics Holdings Inc. insider buys or sells ETTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Entasis Therapeutics Holdings Inc.

Track Activities on ETTX

Account